References

  1. Burnham-Marusich AR, Ezeanolue CO, Obiefune MC, Yang W, Osuji A, Ogidi AG et al. Prevalence of Sickle Cell Trait and Reliability of Self-Reported Status among Expectant Parents in Nigeria: Implications for Targeted Newborn Screening. Public Health Genomics. 2016; 19(5): 298-306. PubMed | Google Scholar

  2. Piel FB, Howes RE, Patil AP, Nyangiri OA, Gething PW, Bhatt S et al. The distribution of haemoglobin C and its prevalence in newborns in Africa. Sci Rep. 2013; 3: 1671. PubMed | Google Scholar

  3. Mario N, Sala N. Diagnostic biologique des hémoglobinopathies. Revue Francophone des Laboratoires. 2016; 481: 36-39. Google Scholar

  4. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M et al. Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates. Lancet. 12 janv 2013; 381(9861): 142-51. PubMed | Google Scholar

  5. Chakravorty S, Williams TN. Sickle cell disease: a neglected chronic disease of increasing global health importance. Arch Dis Child. Janv 2015; 100(1): 48-53. PubMed | Google Scholar

  6. Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Williams TN et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2 Nov 2010; 1: 104. PubMed | Google Scholar

  7. Ojodu J, Hulihan MM, Pope SN, Grant AM, Centers for Disease Control and Prevention (CDC). Incidence of sickle cell trait United States, 2010. MMWR Morb Mortal Wkly Rep. 12 Déc 2014; 63(49): 1155-8. PubMed | Google Scholar

  8. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. Avr 2010; 38(4 Suppl): S512-521. PubMed | Google Scholar

  9. Chaturvedi S, DeBaun MR. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years. Am J Hematol. Janv 2016; 91(1): 5-14. PubMed | Google Scholar

  10. Tshilolo L, Aissi LM, Lukusa D, Kinsiama C, Wembonyama S, Gulbis B et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol. Janv 2009; 62(1): 35-8. PubMed | Google Scholar

  11. Agasa B, Bosunga K, Opara A, Tshilumba K, Dupont E, Vertongen F et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? Transfus Med. Févr 2010; 20(1): 62-5. Google Scholar

  12. De Montalembert M, Tshilolo L. [Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa?]. Med Trop (Mars). Déc 2007; 67(6): 612-6. PubMed | Google Scholar

  13. Driscoll MC. Sickle cell disease. Pediatr Rev. Juill 2007; 28(7): 259-68. PubMed | Google Scholar

  14. M'pemba L, N'Zingoula S. Le statut vaccinal de l'enfant drépanocytaire homozygote congolais. Med Afr Noire. 2004; 51: 37-41.

  15. Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 10 Sept 2014; 312(10): 1033-48. PubMed | Google Scholar

  16. Tshilolo L, Bahwe M, Vertongen F. les anomalies de la sphère ORL et buccodentaires observées chez les drépanocytaires Zairois. Nouv Rev Fr hematol. 1995; 37(1): 4.

  17. Bartolucci P, Habibi A, Stehlé T, Di Liberto G, Rakotoson MG, Gellen-Dautremer J et al. Six months of hydroxyurea reduces albuminuria in patients with sickle cell disease. J Am Soc Nephrol. 2016; 27(6): 1847-53. PubMed | Google Scholar

  18. Neonato MG, Guilloud-Bataille M, Beauvais P, Bégué P, Belloy M, Benkerrou M et al. Acute clinical events in 299 homozygous sickle cell patients living in France. French Study Group on Sickle Cell Disease. Eur J Haematol. Sept 2000; 65(3): 155-64. PubMed | Google Scholar

  19. Tshilolo L, Mukendi R, Girot R. Drépanocytose dans le sud du Zaïre: étude de deux séries de 251 et 340 malades suivis entre 1988 et 1992. Archives de Pédiatrie. 1994; 3(2): 104-11. PubMed | Google Scholar

  20. Gage TP, Gagnier JM. Ischemic colitis complicating sickle cell crisis. Gastroenterology. Janv 1983; 84(1): 171-4. PubMed | Google Scholar

  21. Krauss JS, Freant LJ, Lee JR. Gastrointestinal pathology in sickle cell disease. Ann Clin Lab Sci. Févr 1998; 28(1): 19-23. PubMed | Google Scholar

  22. Embury SH. Sickle cell disease: basic principles and clinical practice. New York: Raven Press. 1994; 902. Google Scholar

  23. Bond LR, Hatty SR, Horn ME, Dick M, Meire HB, Bellingham AJ. Gall stones in sickle cell disease in the United Kingdom. Br Med J (Clin Res Ed). 25 Juill 1987; 295(6592): 234-6. PubMed | Google Scholar

  24. Webb DK, Darby JS, Dunn DT, Terry SI, Serjeant GR. Gall stones in Jamaican children with homozygous sickle cell disease. Arch Dis Child. Mai 1989; 64(5): 693-6. PubMed | Google Scholar

  25. Ahmed SG, Uraka J. Impact of intestinal parasites on haematological parameters of sickle-cell anaemia patients in Nigeria. East Mediterr Health J. Sept 2011; 17(9): 710-3. PubMed | Google Scholar

  26. Porter JB, Huehns ER. Transfusion and exchange transfusion in sickle cell anaemias, with particular reference to iron metabolism. Acta Haematol. 1987; 78(2-3): 198-205. PubMed | Google Scholar

  27. Ouédraogo-Yugbaré SO, Tiendrebeogo J, Koueta F, Sawadogo H, Dao L, Ouédraogo P et al. Syndromes drépanocytaires majeurs chez les enfants de 0 à 15 ans à Ouagadougou: marqueurs génétiques et caractéristiques cliniques. Pan African Medical Journal. 2014;19:215. Google Scholar

  28. Yé D, Kouéta F, Dao L, Kaboret S, Sawadogo A. Prise en charge de la drépanocytose en milieu pédiatrique: expérience du centre hospitalier universitaire pédiatrique Charles-de-Gaulle de Ouagadougou (Burkina Faso). Cahiers de Santé. Avr 2008; 2: 071-075. Google Scholar

  29. Nacoulma E, Kam L, Gue EE, Kafando E, Ayereroue J, Blot I. Évaluation du statut vaccinal de l'enfant drépanocytaire de la ville de Ouagadougou (Burkina Faso). Cahiers d'études et de recherches francophones / Santé. 2006; 16(3): 155-60. Google Scholar

  30. Wierenga KJ, Hambleton IR, Wilson RM, Alexander H, Serjeant BE, Serjeant GR. Significance of fever in Jamaican patients with homozygous sickle cell disease. Arch Dis Child. Févr 2001; 84(2): 156-9. PubMed | Google Scholar

  31. Latoundji S, Anani L, Ablet E, Zohoun I. Morbidité et mortalité drépanocytaire au bénin. Med Afr Noire. 1991;38(8/9): 571-6.

  32. Douamba S, Nagalo K, Tamini L, Traoré I, Kam M, Kouéta F et al. [Major sickle cell syndromes and infections associated with this condition in children in Burkina Faso]. Pan Afr Med J. 2017; 26: 7. PubMed | Google Scholar

  33. Gbadoé AD, Atsou K, Agbodjan-Djossou OA, Tsolényanu E, Nyadanu M, Dogba AD et al. [Ambulatory management of sickle cell disease: evaluation of the first year follow up of patients in the pediatric department of Lomé (Togo)]. Bull Soc Pathol Exot. Mai 2001; 94(2): 101-5. PubMed | Google Scholar

  34. Mukinayi BM, Kalenda DK, Mbelu S, Gulbis B. [Awareness and attitudes of 50 congolese families affected by sickle cell disease: a local survey]. Pan Afr Med J. 2018; 29: 24. PubMed | Google Scholar

  35. Dodo R, Zohoun A, Baglo T, Mehou J, Anani L. [Emergency treatment of sickle cell diseases in the Blood Diseases Department at the Koutoukou Maga National Teaching Hospital, Cotonou, Benin]. Pan Afr Med J. 2018; 30: 192. PubMed | Google Scholar

  36. Johnson CS, Omata M, Tong MJ, Simmons JF, Weiner J, Tatter D. Liver involvement in sickle cell disease. Medicine (Baltimore). Sept 1985; 64(5): 349-56. PubMed | Google Scholar

  37. Rushikesh S, Taborda C, Chawla S. Acute and chronic hepatobiliary manifestations of sickle cell disease: A review. MWorld J Gastrointest Pathophysiol. 2017 Aug 15; 8(3): 108-116. PubMed | Google Scholar

  38. Mbika Cardorelle A, Okoko A, Mouko A. [Vaso-occlusive crisis of sickle cell child in Brazzaville drugs news]. Arch Pediatr. Mars 2010; 17(3): 295-6. Google Scholar

  39. Perignon A, Botterel F, Farrugia C, Foulet F, Bachir D, Galacteros F et al. C-02 Paludisme et drépanocytose homozygote. Médecine et Maladies Infectieuses. Juin 2008; 38: S140. Google Scholar

  40. Allison AC. Protection afforded by sickle-cell trait against subtertian malareal infection. Br Med J. 6 Févr 1954; 1(4857): 290-4. PubMed | Google Scholar

  41. Taylor SM, Cerami C, Fairhurst RM. Hemoglobinopathies: slicing the Gordian knot of Plasmodium falciparum malaria pathogenesis. PLoS Pathog. 2013; 9(5): e1003327. PubMed | Google Scholar

  42. Meshikhes AW. Gastroenterological manifestations of sickle cell disease. Saudi J Gastroenterol. Janv 1997; 3(1): 29-33. PubMed | Google Scholar

  43. Lee MG, Thirumalai CH, Terry SI, Serjeant GR. Endoscopic and gastric acid studies in homozygous sickle cell disease and upper abdominal pain. Gut. Mai 1989; 30(5): 569-72. PubMed | Google Scholar

  44. Rao S, Royal JE, Conrad HA, Harris V, Ahuja J. Duodenal ulcer in sickle cell anemia. J Pediatr Gastroenterol Nutr. Janv 1990; 10(1): 117-20. PubMed | Google Scholar

  45. Koskinas J, Manesis EK, Zacharakis GH, Galiatsatos N, Sevastos N, Archimandritis AJ. Liver involvement in acute vaso-occlusive crisis of sickle cell disease: prevalence and predisposing factors. Scand J Gastroenterol. Avr 2007; 42(4): 499-507. PubMed | Google Scholar

  46. Ebert EC, Nagar M, Hagspiel KD. Gastrointestinal and hepatic complications of sickle cell disease. Clin Gastroenterol Hepatol. Juin 2010; 8(6):483-9; quiz e70. PubMed | Google Scholar

  47. Meremikwu MM, Okomo U. Sickle cell disease. BMJ Clin Evid. BMJ Clin Evid. 2016 Jan 22; 2016. pii: 2402. PubMed | Google Scholar

  48. Shome DK, Al Ajmi A, Radhi AA, Mansoor EJ, Majed KS. The effect of hydroxyurea therapy in Bahraini sickle cell disease patients. Indian Journal of Hematology and Blood Transfusion. Mars 2016; 32(1): 104-9. PubMed | Google Scholar